Notice pursuant to chapter 9, section 5 of the securities market act

Revenio Group Corporation, Stock Exchange Release, January 24, 2018 at 18:00 EET

Notice pursuant to chapter 9, section 5 of the securities market act

Revenio Group Corporation has January 24, 2018 received a notification of change in holdings in accordance with Chapter 9, Section 5 of the Securities Markets Act that SMALLCAP World Fund, Inc.'s share of the total number of shares and voting rights in Revenio Group Corporation has increased to more than five per cent.

SMALLCAP World Fund, Inc. now holds 1.262.791 shares in Revenio Group Corporation, which is 5.2580 per cent of the company's shares and voting rights.

The total number of Revenio Group Corporation's shares recorded in the trade register is 24.016.476 shares.

Revenio Group Corporation

Timo Hildén

President and CEO

For further information, please contact:

CEO & President Timo Hildén Telephone: +358 40 580 4774 timo.hilden@revenio.fi www.revenio.fi www.ventica.fi

DISTRIBUTION:

Nasdaq Helsinki

Financial Supervisory Authority (FIN-FSA)

Principal media www.revenio.fi

The Revenio Group in brief

Revenio is a Finnish, globally operating health technology corporation whose worldwide success is based on a strongly patented intraocular pressure measurement technology. The Revenio Group consists of Icare Finland Oy, Revenio Research Oy and Oscare Medical Oy. The common denominators of Revenio's business operations include screening, follow-up and the global need to make cost savings through preventive health care. Revenio seeks vigorous growth in health technology. Revenio aims to develop even more efficient and easily adopted methods for the early-stage detection of diseases with significance for public health. The focus of Revenio's screening technology is on the early detection of glaucoma, osteoporosis, skin cancer and asthma, and the monitoring of these during the treatment process.

In 2017, Revenio Group's net sales totaled EUR 26.8 million, with its operating margin, excluding non-recurring items, standing at 35.5%. Revenio Group Corporation is listed on Nasdaq Helsinki.